Time and Financial Toxicity Implications during Consideration of Pembrolizumab Infusion Frequency

Autor: Nori, S., Strohbehn, G., Bryant, A.K.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:e778-e778
Databáze: ScienceDirect